EPT 100: Geranium Oil for the Relief of Neuropathic Pain

Neuropathic Pain Clinical Trial

— Geranium Oil  

Official title:

EPT 100: Geranium Oil for the Relief of Neuropathic Pain

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01007747
• Other study ID #: PBRC 21033
• Status: Completed
• Phase: N/A
• First received: November 3, 2009
• Last updated: December 17, 2015
• Start date: November 2008
• Est. completion date: October 2011

Study information

• Verified date: December 2015
• Source: Pennington Biomedical Research Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine if Geranium oil will relieve a variety of neuropathic pain and some pain relief will last more than 48 hours.

Description:

EPT 100 study is designed to identify the percentage of people who experience neuropathic pain relief from topical geranium oil from Reunion Island, determine which neuropathic pain conditions respond best and define the time course of the pain relief.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 166
• Est. completion date: October 2011
• Est. primary completion date: June 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years of age or oler

• Neuralgia or neuropathy with daily pain

• At least moderate intensity pain

• Signed informed consent

Exclusion Criteria:

• Pregnant or nursing

• Known allergies to geranium oil or geranium oil fractions

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Neuralgia
• Neuropathic Pain

Intervention

Other:
• Geranium oil
Daily topical application over neuropathic pain

Locations

Country	Name	City	State
United States	Pennington Biomedical Research Center	Baton Rouge	Louisiana

Sponsors (1)

Lead Sponsor	Collaborator
Pennington Biomedical Research Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain relief		3 times in 30 to 60 minutes post-application	No
Secondary	Response to therapy at 30 to 60 minutes, they will be asked to apply the oil to painful area daily		Daily over 1 week	No